Why the study?
Evaluating the extent to which sex and gender differences in Alzheimer's dementia are driven by longevity, survival bias, comorbidities, and other differential risk factors is critical for planning prevention trials.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Multiple factors beyond hormones shape sex differences in AD; leaves open whether findings inform sex-specific prevention or care.
Reviewing the research presented in this article, it is evident that from an epidemiological perspective, it is important to evaluate the extent to which findings of sex and gender differences in Alzheimer's dementia (AD) are due to differences in longevity, survival bias, and comorbidities. Medical, genetic, psychosocial, and behavioral factors, in addition to hormonal factors, can differentially affect the risk and progression of AD in women versus men. Further, evaluation of sex differences in AD progression and the trajectory of change in cognitive function, neuroimaging, cerebrospinal fluid (CSF), and blood-based biomarkers of AD is needed. Finally, identifying sex differences in AD biomarkers and change across the lifespan is critical for the planning of prevention trials to reduce the risk of developing AD.
No takes yet. Share an insight, caveat, or question.
Aggarwal et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: